- ISCO Has Promising Therapy For Parkinson's Disease
- An Interview With Leo Ehrlich, Cellceutix CEO
- International Stem Cell Corp $ISCO Appears To Be Breaking Out From Downtrend
- Which Drug Moves Cellceutix First: Kevetrin Or Prurisol?
- Cellceutix Drug Kevetrin Achieves In-Vivo Tumor Shrinkage In Renal Cancer
KarinCA
KarinCA
Send Message
KarinCA
Stop FollowingKarinCA
ABOUT
I'm an independent trader whose primary interests are in the stem cell and biotech arena. My secondary interest is in oil/energy.
Investment Philosophy: Understand why you are getting in and cut your loss immediately if PPS goes down while behaving differently than you expected. Don't ride it down!
I'm not a financial advisor & only give my opinions. Seek expert advice elsewhere. ;)
My positions, long or short can change dramatically as new information comes to my attention.
And, don't follow me into a penny stock without realizing they are HIGHLY risky and you can lose ALL of your investment.
Please feel free to follow me at https://twitter.com/KarinCAtrades
...More
Be kinder than necessary, for everyone you meet is fighting some kind of battle. ;)
Investment Philosophy: Understand why you are getting in and cut your loss immediately if PPS goes down while behaving differently than you expected. Don't ride it down!
I'm not a financial advisor & only give my opinions. Seek expert advice elsewhere. ;)
My positions, long or short can change dramatically as new information comes to my attention.
And, don't follow me into a penny stock without realizing they are HIGHLY risky and you can lose ALL of your investment.
Please feel free to follow me at https://twitter.com/KarinCAtrades
...More
Be kinder than necessary, for everyone you meet is fighting some kind of battle. ;)
SNAPSHOT
- Description: Independent trader. Trading frequency: Weekly
- Interests: Dividend stock ideas & income, Options, Retirement savings, Stocks - long
COMPANY
Currently, there is no company profile for KarinCA.
BLOG
Currently, there are no blog details for KarinCA.
Book
Currently, there are no book details for KarinCA.
LATEST STOCKTALK
more »
$ISCO - to Host Conference Call on Friday, March 22 to Discuss Positive Study Data of Parkinson's Disease - http://tinyurl.com/cb6r492
Mar 21, 2013
Latest Comments
more »
- Equity Options Guru... yes,... on 3 Small Cap Cancer Stocks With Upcoming Catalysts
- pgathua... Investing in ear... on 3 Small Cap Cancer Stocks With Upcoming Catalysts
- Great article, but, I'd hav... on 3 Small Cap Cancer Stocks With Upcoming Catalysts
- Hope4Future… The ASCO meeti... on Cellceutix Corporation: The Next Generation Of ...
- Hope4Future… As a contribut... on Cellceutix Corporation: The Next Generation Of ...
Latest comments on KarinCA's Articles
- biomanbaba on Why The Aspire Deal Is A Winner For Cellceutix ...
- seelisa on Which Drug Moves Cellceutix First: Kevetrin Or ...
- MICROBIOBOB on Which Drug Moves Cellceutix First: Kevetrin Or ...
- seelisa on Which Drug Moves Cellceutix First: Kevetrin Or ...
- The Progressive on An Interview With Leo Ehrlich, Cellceutix CEO
LATEST ARTICLES & INSTAPOSTS
more »
